One would think that there must be a faster way to bring pain relief to those suffering from pain considering the amount data that we have in regards to CLBP , RA and aGVHD ( extending to EB in Japan )
Considering the safety profile of these therapies perhaps a limited market release for the purpose of sustainable pain relief and management of opioid addiction would be possible.
Unfortunately common sense is not a strong point of Western regulators.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.80 |
Change
-0.055(2.97%) |
Mkt cap ! $2.293B | |||
| Open | High | Low | Value | Volume |
| $1.84 | $1.86 | $1.77 | $7.241M | 4.018M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 25472 | $1.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.81 | 1500 | 1 |
View Market Depth
| Last trade - 16.10pm 13/06/2025 (20 minute delay) ? |
| MSB (ASX) Chart |